---
title: "礼来药物与 Wegovy 联用可减少肌肉流失"
description: "研究显示，礼来药物 bimagrumab 与诺和诺德的减肥药 Wegovy 联合使用，能有效减少肌肉流失。根据在美国糖尿病协会年会公布的结果，患者在 48 周内体重下降 22.1%，其中 92.8% 为体脂减少。这一研究为肥胖药物的肌肉流失问题提供了潜在解决方案。礼来股价上涨超过 3%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/245725786.md"
published_at: "2025-06-23T13:42:53.000Z"
---

# 礼来药物与 Wegovy 联用可减少肌肉流失

> 研究显示，礼来药物 bimagrumab 与诺和诺德的减肥药 Wegovy 联合使用，能有效减少肌肉流失。根据在美国糖尿病协会年会公布的结果，患者在 48 周内体重下降 22.1%，其中 92.8% 为体脂减少。这一研究为肥胖药物的肌肉流失问题提供了潜在解决方案。礼来股价上涨超过 3%。

研究显示，患者在使用诺和诺德减肥药 Wegovy 的同时，联合服用礼来的实验性药物 bimagrumab，在减重的同时能够有效保持肌肉质量。据周一在芝加哥举行的美国糖尿病协会年会公布的结果，联合用药的患者在 48 周内体重下降了 22.1%，其中 92.8% 为体脂减少。该研究结果为当前流行的肥胖药物带来的肌肉流失问题提供了潜在解决方案。目前，研究人员还在探索其他药物组合，但这些组合可能带来更多副作用风险。礼来现涨超 3%。

### Related Stocks

- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026 | Eli Lilly's stock is surging due to AI deals and a favorable drug pricing agreement. The healthcare sector, particularly | [Link](https://longbridge.com/zh-CN/news/267579204.md) |
| Eli Lilly joins a very exclusive club | Eli Lilly becomes the eleventh company to surpass $1 trillion in market capitalization, marking a milestone for healthca | [Link](https://longbridge.com/zh-CN/news/267672421.md) |
| Did Analyst Upgrades and Metal Price Tailwinds Just Shift Coeur Mining's (CDE) Investment Narrative? | Recent analyst upgrades for Coeur Mining, alongside rising gold and silver prices, have shifted focus on the company's c | [Link](https://longbridge.com/zh-CN/news/275995095.md) |
| A Goldman Sachs partner in technology shares the skills young job seekers need in the AI workplace | A Goldman Sachs partner in technology shares the skills young job seekers need in the AI workplace | [Link](https://longbridge.com/zh-CN/news/275976341.md) |
| Aberdeen Group plc Has $144.09 Million Position in Arista Networks, Inc. $ANET | Aberdeen Group plc increased its stake in Arista Networks, Inc. by 1.4% in Q3, owning 1,005,027 shares valued at $144.09 | [Link](https://longbridge.com/zh-CN/news/275999141.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。